| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |